Prolinamide-tetrazole derivatives as NK3 receptor antagonists

Details for Australian Patent Application No. 2008258664 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Wu, Xihan; Nettekoven, Matthias; Han, Bo; Knust, Henner; Ratni, Hasane

Agent Spruson & Ferguson

Pub. Number AU-B-2008258664 ( Modified Examination )

PCT Pub. Number WO2008/148688

Priority 07109783.6 07.06.07 EP

Filing date 29 May 2008

Wipo publication date 11 December 2008

Acceptance publication date 5 July 2012

International Classifications

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/496 - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61P 25/00 Drugs for disorders of the nervous system

Event Publications

24 December 2009 PCT application entered the National Phase

  PCT publication WO2008/148688 Priority application(s): WO2008/148688

14 January 2010 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the Corrigenda Name F.Hoffmann-La Roche AG, Application No. 2008258664, under INID (71) correct the applicant to read F. Hoffmann-La Roche AG

5 July 2012 Application Accepted

  Published as AU-B-2008258664 ( Modified Examination )

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008258665-Prolinamide derivatives as NK3 antagonists

2008258653-Method for filtering a suspension and filter device